PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.
Abstract Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with reductions in both the concentration of LDL cholesterol and the risk of coronary heart disease, but…